Further, following incubation of LNCaP cells with melatonin, genomic microarray found the indolamine to upregulate insulin-like growth factor-binding protein 3 (IGFBP3), a gene target determined to underlie the melatonin-mediated NE differentiation of prostate cancer cells. This evidence concerns the gene IGFBP3 and prostate carcinoma.